Abstract
829 The epidermal growth factor receptor tyrosine kinase inhibitor gefitinib (‘iressa’, ZD-1839) and the protein prenyltransferase inhibitor M365408 as potential therapeutics in bladder cancer
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have